NeuroOne Medical Technologies Corporation Statistics
Share Statistics
NeuroOne Medical Technologies Corporation has 30.81M shares outstanding. The number of shares has increased by 28.58% in one year.
| Shares Outstanding | 30.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 10.67% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 26.61M |
| Failed to Deliver (FTD) Shares | 615 |
| FTD / Avg. Volume | 0.5% |
Short Selling Information
The latest short interest is 122.75K, so 0.4% of the outstanding shares have been sold short.
| Short Interest | 122.75K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 2.07 |
Valuation Ratios
The PE ratio is -1.36 and the forward PE ratio is -3.18.
| PE Ratio | -1.36 |
| Forward PE | -3.18 |
| PS Ratio | 8.26 |
| Forward PS | 2.4 |
| PB Ratio | 2.58 |
| P/FCF Ratio | -1.22 |
| PEG Ratio | n/a |
Enterprise Valuation
NeuroOne Medical Technologies Corporation has an Enterprise Value (EV) of 11.00M.
| EV / Earnings | -0.93 |
| EV / Sales | 5.63 |
| EV / EBITDA | -0.94 |
| EV / EBIT | -0.92 |
| EV / FCF | -0.83 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.
| Current Ratio | 4.08 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.9% and return on capital (ROIC) is -185.82%.
| Return on Equity (ROE) | -1.9% |
| Return on Assets (ROA) | -1.46% |
| Return on Capital (ROIC) | -185.82% |
| Revenue Per Employee | 122.03K |
| Profits Per Employee | -741.22K |
| Employee Count | 16 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -49.02% in the last 52 weeks. The beta is 0.91, so NeuroOne Medical Technologies Corporation's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | -49.02% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 51.67 |
| Average Volume (20 Days) | 122.21K |
Income Statement
In the last 12 months, NeuroOne Medical Technologies Corporation had revenue of $1.95M and earned -$11.86M in profits. Earnings per share was $-0.65.
| Revenue | 1.95M |
| Gross Profit | 456.52K |
| Operating Income | -11.96M |
| Net Income | -11.86M |
| EBITDA | -11.76M |
| EBIT | -11.96M |
| Earnings Per Share (EPS) | -0.65 |
Balance Sheet
The company has $5.32M in cash and $184.40K in debt, giving a net cash position of $5.14M.
| Cash & Cash Equivalents | 5.32M |
| Total Debt | 184.40K |
| Net Cash | 5.14M |
| Retained Earnings | -62.69M |
| Total Assets | 4.91M |
| Working Capital | 2.39M |
Cash Flow
In the last 12 months, operating cash flow was -$12.89M and capital expenditures -$384.12K, giving a free cash flow of -$13.27M.
| Operating Cash Flow | -12.89M |
| Capital Expenditures | -384.12K |
| Free Cash Flow | -13.27M |
| FCF Per Share | -0.73 |
Margins
Gross margin is 23.38%, with operating and profit margins of -612.32% and -607.42%.
| Gross Margin | 23.38% |
| Operating Margin | -612.32% |
| Pretax Margin | -607.42% |
| Profit Margin | -607.42% |
| EBITDA Margin | -602.12% |
| EBIT Margin | -612.32% |
| FCF Margin | -679.71% |
Dividends & Yields
NMTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -83.33% |
| FCF Yield | -55.22% |
Analyst Forecast
Currently there are no analyst rating for NMTC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 1, 2021. It was a backward split with a ratio of 1:3.
| Last Split Date | Apr 1, 2021 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -19.17 |
| Piotroski F-Score | 2 |